Posting Progress

In the beginning, there were no posters. Now, many scientific meetings have thousands of them. At the 50th meeting of the American Society of Human Genetics (ASHG) in Philadelphia, Oct. 4-7, scientists signed up for 2,147 posters, compared to 287 slide presentations. Douglas Marchuk, associate professor in the department of genetics at Duke University, and this year's head of the ASHG program committee, describes the poster evolution this way: "In l977 and l978 they were all slide sessions. In

Written byJean Mccann
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In the beginning, there were no posters. Now, many scientific meetings have thousands of them. At the 50th meeting of the American Society of Human Genetics (ASHG) in Philadelphia, Oct. 4-7, scientists signed up for 2,147 posters, compared to 287 slide presentations.

Douglas Marchuk, associate professor in the department of genetics at Duke University, and this year's head of the ASHG program committee, describes the poster evolution this way: "In l977 and l978 they were all slide sessions. In l979 we went to posters, and it was a 50-50 mix, but by l982, it was 28 percent slides and 82 percent posters. This year it was 88 percent posters and 12 percent slide sessions."

He added that some people check off "poster only" when they submit their abstracts online, and they occasionally have to be persuaded to give a slide session instead. In other instances, there is a certain amount ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies